Mr Nicholas Kallas > Venable LLP > New York, United States > Lawyer Profile
Venable LLP Offices
1270 AVENUE OF THE AMERICAS, THE TWENTY-FOURTH FLOOR
NEW YORK, NY 10020
- Go to...
Mr Nicholas Kallas
Intellectual Property: Litigation • Pharmaceuticals • Chemicals.
Nicholas N. Kallas, Ph.D., has over 30 years of patent law experience, focusing primarily on patent litigation and pre-suit investigations in matters related to pharmaceuticals, chemicals, food and consumer products. Mr. Kallas has significant trial (including jury trial) and appellate experience. Specific technologies Mr. Kallas has worked with include anti-fungal, herpes, breast cancer, osteoporosis, anti-cholesterol, ophthalmic, anti-cholinesterase, and immunosuppressant drugs; microemulsion, enteric coating, and delayed release pharmaceutical formulations; and crystalline drug products. Mr. Kallas has served as trial counsel for Novartis, American-Maize Products, S.C. Johnson & Son and Parker Laboratories, in addition to representing Warner-Lambert, Bristol-Myers Squibb, Union Carbide, Crompton & Knowles, Merck and Triarco Industries. Mr. Kallas has made presentations at A.I.P.L.A. and local patent bar associations on such topics as U.S. patent prosecution practices from a litigator’s point of view and accounting damages in patent litigations.
American Bar Association; American Intellectual Property Law Association; New York Bar Association; New York Intellectual Property Law Association; Federal Circuit Bar Association; Institute of Food Technologists.
J.D. with honors, Ohio State University Law School, 1982 Ph.D., Food Science, Ohio State University, 1979 Master’s in Food Science, Ohio State University, 1977 B.S. Microbiology, Ohio State University, 1974.
United States > Intellectual property > Patents: litigation (full coverage)
Venable LLP acquired New York IP boutique Fitzpatrick, Cella, Harper & Scinto and now has particular strength in the electronics and life science sectors, with an especially busy practice for branded pharmaceutical companies. Michael Sandonato, who chairs the ITC litigation practice with Edmund Haughey, obtained a precedential PTAB decision for long-standing client Canon regarding five ultimately denied follow-on IPRs that General Plastic Industrial had filed. Nicholas Kallas successfully defended two Novartis patents covering the use of the drug Afinitor against invalidity claims brought forward by West-Ward Pharmaceuticals in the district court of Delaware. Washington DC’s Justin Oliver directs the PTAB practice, while Justin Pierce, also in Washington DC, chairs the intellectual property department with New York’s Dominick Conde. Scott Reed and Washington DC-based Megan Woodworth jointly head the intellectual property litigation practice. Christopher Borello in New York is also noted. Charlotte Jacobsen joined Ropes & Gray LLP before the merger, and Tamany Vinson Bentz joined DLA Piper LLP (US). Additional clients include biopharmaceutical player Alkermes, Sanofi and Allergan.
Top Tier Firm Rankings
- M&A/corporate and commercial > M&A: middle-market (sub-$500m)
- Tax > Not-for-profit (Fortune 1000 private foundations, and national trade associations and charities)
- Media, technology and telecoms > Advertising and marketing: litigation
- Media, technology and telecoms > Advertising and marketing: transactional
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Government > Government contracts
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Finance > Financial services regulation